Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Grace Therapeutics, Inc.Listing on record | Buy | $214K | conv 91First in 12mo | SEC | |
Grace Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Grace Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Grace Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Grace Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Grace Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |